These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 16408448)

  • 1. [Diagnostic criteria for diabetes in older subjects].
    Ugi S; Kashiwagi A
    Nihon Rinsho; 2006 Jan; 64(1):57-63. PubMed ID: 16408448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
    Adam JM; Tarigan NP
    Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value and significance of new diagnostic criteria of diabetes mellitus in older people.
    Motta M; Bennati E; Ferlito L; Passamonte M; Malaguarnera M
    Arch Gerontol Geriatr; 2007; 45(1):103-8. PubMed ID: 17140679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
    Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels?
    Ko GT; Cockram CS; Chan JC
    J Med; 2001; 32(1-2):53-65. PubMed ID: 11321888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired fasting glycaemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: population-based, cross-sectional study of risk factors for cardiovascular disease.
    Heldgaard PE; Olivarius Nde F; Hindsberger C; Henriksen JE
    Diabet Med; 2004 Apr; 21(4):363-70. PubMed ID: 15049940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of fasting plasma glucose as a screening test for diabetes mellitus in Singaporean adults.
    Lee CH; Fook-Chong S
    Diabet Med; 1997 Feb; 14(2):119-22. PubMed ID: 9047088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn study.
    Rijkelijkhuizen JM; Nijpels G; Heine RJ; Bouter LM; Stehouwer CD; Dekker JM
    Diabetes Care; 2007 Feb; 30(2):332-6. PubMed ID: 17259503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes].
    Köhler C; Temelkova-Kurktschiev T; Schaper F; Fücker K; Hanefeld M
    Dtsch Med Wochenschr; 1999 Sep; 124(37):1057-61. PubMed ID: 10520305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated post-challenge hyperglycemia: concept and clinical significance.
    Adam JM; Josten D
    Acta Med Indones; 2008 Jul; 40(3):171-5. PubMed ID: 18838757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon.
    Sharif A; Moore RH; Baboolal K
    Transplantation; 2006 Dec; 82(12):1667-72. PubMed ID: 17198257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of impaired fasting glucose and impaired glucose tolerance on arterial stiffness in an older Chinese population: the Guangzhou Biobank Cohort Study-CVD.
    Xu L; Jiang CQ; Lam TH; Cheng KK; Yue XJ; Lin JM; Zhang WS; Thomas GN
    Metabolism; 2010 Mar; 59(3):367-72. PubMed ID: 19828159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misclassification of subjects with insulin resistance and associated cardiovascular risk factors by homeostasis model assessment index. Utility of a postprandial method based on oral glucose tolerance test.
    Martinez-Hervas S; Argente C; Garcia-Jodar J; Priego A; Real JT; Carratala A; Carmena R; Ascaso JF
    Metabolism; 2011 May; 60(5):740-6. PubMed ID: 20850158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose: more results from the Paris Prospective Study.
    Balkau B; Forhan A; Eschwège E
    Diabetologia; 2002 Sep; 45(9):1224-30. PubMed ID: 12242454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial lipaemia in patients with impaired fasting glucose, impaired glucose tolerance and diabetes mellitus.
    Madhu SV; Kant S; Srivastava S; Kant R; Sharma SB; Bhadoria DP
    Diabetes Res Clin Pract; 2008 Jun; 80(3):380-5. PubMed ID: 18321605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes screening after gestational diabetes mellitus: poor performance of fasting plasma glucose.
    Cypryk K; Czupryniak L; Wilczyński J; Lewiński A
    Acta Diabetol; 2004 Mar; 41(1):5-8. PubMed ID: 15057547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.
    DECODE Study Group, the European Diabetes Epidemiology Group.
    Arch Intern Med; 2001 Feb; 161(3):397-405. PubMed ID: 11176766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-hour post-challenge glucose is a better predictor of adverse outcome after myocardial infarction than fasting or admission glucose in patients without diabetes.
    Chattopadhyay S; George A; John J; Sathyapalan T
    Acta Diabetol; 2018 May; 55(5):449-458. PubMed ID: 29450734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-linear contribution of glucose measures to cardiovascular diseases and mortality: reclassifying the Framingham's risk categories: a decade follow-up from the Tehran lipid and glucose study.
    Yadegari H; Bozorgmanesh M; Hadaegh F; Azizi F
    Int J Cardiol; 2013 Aug; 167(4):1486-94. PubMed ID: 22578948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How I explore ... the controversy concerning the role of oral glucose tolerance test in clinical practice].
    Luyckx FH; Scheen AJ
    Rev Med Liege; 2003 Nov; 58(11):701-5. PubMed ID: 14748199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.